B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies
Outcomes of patients with multiple myeloma (MM) who become refractory to standard therapies are particularly poor and novel agents are greatly needed to improve outcomes in such patients. B-cell maturation antigen (BCMA) has become an important therapeutic target in MM with three modalities of treat...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2021-01-01
|
| シリーズ: | Therapeutic Advances in Hematology |
| オンライン･アクセス: | https://doi.org/10.1177/2040620721989585 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|